Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details)

v3.22.2.2
Commitments and Contingencies (Details)
£ in Millions
 1 Months Ended 12 Months Ended
Dec. 31, 2019
USD ($)
May 31, 2022
USD ($)
item
D
May 31, 2022
GBP (£)
Jan. 31, 2022
USD ($)
Jan. 06, 2022
USD ($)
Research, Development And Manufacturing Agreements With Samsung [Member]          
Loss Contingencies [Line Items]          
Forecast period   3 years      
Amount of material breach of' Master Services and Project Specific Agreements         $ 13,500,000
Additional Contractual Obligation       $ 22,800,000  
Contractual Obligation   $ 232,788,000      
Contractual Obligation, Fiscal Year Maturity [Abstract]          
2023   34,638,000      
2024   121,750,000      
2025   76,400,000      
Total   $ 232,788,000      
License Agreements With Vyera Pharmaceuticals, LLC          
Contractual Obligation, Fiscal Year Maturity [Abstract]          
Amount payable upon achievement of sales and regulatory milestone $ 85,300,000        
Percentage of royalty payable by the counter party 50.00%        
Term of arrangement 10 years        
Term of arrangement, after first commercial sale 2 years        
Number of days of prior written notice | D   180      
Progenics Purchase Agreement [Member]          
Contractual Obligation, Fiscal Year Maturity [Abstract]          
Amount of milestone payments payable   $ 5,000,000      
Percentage of royalty payable   3.50%      
Amount payable upon filing BLA with FDA   $ 500,000      
Amount payable upon FDA approval   500,000      
Annual maintenance fees   $ 150,000      
Progenics Purchase Agreement [Member] | Royalty Payable in Initial 10 Years [Member]          
Contractual Obligation, Fiscal Year Maturity [Abstract]          
Percentage of royalty payable   5.00%      
Lonza Agreement          
Contractual Obligation, Fiscal Year Maturity [Abstract]          
Number of contract manufacturers | item   2      
Annual license fee   $ 700,000 £ 0.6    
Royalty on net sales (as a percent)   2.00% 2.00%    
Accounts Payable | Research, Development And Manufacturing Agreements With Samsung [Member]          
Loss Contingencies [Line Items]          
Contractual Obligation   $ 38,100,000      
Contractual Obligation, Fiscal Year Maturity [Abstract]          
Total   $ 38,100,000